Out-licensing

Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More

Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More

Enhancing the dissolution performance of small and large molecules in a range of dosage forms More

This is a highly effective vaccine suitable for children and should find utility in endemic regions and as a traveler's vaccine. More

The present invention utilizes the characteristic chemical property of hydrazide groups on one reactant to react with aldehyde groups or cyanate esters on the other reactant with an improved conjugate yield of at least sixty percent. More

Methods for SrgT synthesis and suggested modifications for production of SrgT analogs and related peptides More